Cyriac Roeding, CEO and co-founder of cancer therapeutics startup Earli, gives his assessment of China's biotech developments, after predicting a decade ago that the country would become a main competitor to the US. He speaks with Yvonne Man on Bloomberg's The China Show." (Source: Bloomberg)
Cyriac Roeding, CEO and co-founder of cancer therapeutics startup Earli, gives his assessment of China's biotech developments, after predicting a decade ago that the country would become a main competitor to the US. He speaks with Yvonne Man on Bloomberg's The China Show." (Source: Bloomberg)
<iframe src="https://statesidedaily.com/embed/cluster/e4d6fa285910567fb2f70ef042c72486cefd9acf" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Cancer Therapeutics Startup Earli on China Biotech Lead"></iframe>
